Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Edwards Lifesciences has reported Construction in Progress for 3 years, with the latest figure at $301.2 million in Q4 2025.

• On a quarterly basis, Construction in Progress rose 23.44% year-over-year to $301.2 million in Q4 2025; TTM through Dec 2025 was $301.2 million, a 23.44% increase from a year earlier, with the FY2025 full-year figure at $301.2 million, up 23.44% from the prior year.
• Construction in Progress was $301.2 million for Q4 2025 at Edwards Lifesciences, up from $244.0 million in the prior quarter.
• The five-year high for Construction in Progress was $301.2 million in Q4 2025, with the low at $244.0 million in Q4 2024.
• Average Construction in Progress over 3 years is $279.2 million, with a median of $292.5 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Construction in Progress dropped 16.58% in 2024, then rose 23.44% in 2025.
• Over 3 years, Construction in Progress stood at $292.5 million in 2023, then decreased by 16.58% to $244.0 million in 2024, then gained by 23.44% to $301.2 million in 2025.
• The last three Construction in Progress figures came in at $301.2 million (Q4 2025), $244.0 million (Q4 2024), and $292.5 million (Q4 2023), per Business Quant data.